Toby Neugebauer, Fermi's Co-Founder and largest shareholder, has called a Special Meeting on May 29, 2026, giving shareholders their first chance since the IPO to vote on the company's future. Neugebauer criticizes the current board for not pursuing a thorough strategic process and supports exploring all options, including mergers and acquisitions, to maximize shareholder value. He has nominated a new slate of directors and emphasizes the value of Project Matador, a major infrastructure asset developed under his leadership. The meeting will be pivotal for shareholders to influence Fermi's direction amid ongoing strategic discussions and potential transactions.
Riskified Ltd. posted strong Q2 2026 results with revenue rising 22% year-over-year to $98.69 million, its best growth in over four years, driven by rising demand for its e-commerce fraud prevention services. However, earnings per share came in at $0...
Outlook Therapeutics has seen its analyst consensus price target increase from $1.90 to $2.80, driven by promising Phase III trial results for its eye disease drug ONS-5010 and strategic partnerships. The company is expected to beat upcoming quarterl...
Ball Corporation's stock has gained 3.14% over the past month but recently dropped 4.52%, presenting a potential buying opportunity. Analysts forecast a 20.27% growth potential with a target price of $75, reflecting confidence in the company's future...
Kyndryl Holdings, an IT infrastructure services provider spun off from IBM, has seen its stock rise nearly 12% over the past 30 days but recently dipped 3.77% in the last 10 days, possibly creating a buying opportunity. Analysts forecast a 12.85% ups...
The Honest Company reported Q2 earnings of $0.04 per share, doubling expectations, despite a 10.9% revenue drop due to strategic business exits. Organic revenue grew 6.7%, showing strength in core products, while profitability improved with a gross m...
